-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Oruka Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Oruka Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.68M, a 80.9% decline year-over-year.
- Oruka Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$7.2M, a 13.7% decline year-over-year.
- Oruka Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$5.34M, a 46.2% increase from 2022.
- Oruka Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$9.93M, a 48.6% increase from 2021.
- Oruka Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$19.3M, a 98.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)